Yimei Li, PhD
Locations: Main Building
About Yimei Li, PhD
Titles
Faculty Biostatistician
Associate Professor of Biostatistics, Perelman School of Medicine at the University of Pennsylvania
Associate Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Awards and Honors
2009, Student Scholarship Award, Society for Clinical Trials
2998, Jonathan Raz Award, Biostatistics Program, University of Pennsylvania
2006, GlaxoSmithKline Scholar Award, Biostatistics Program, University of Pennsylvania
Leadership and Memberships
Memberships in Professional Organizations
International
2007-Present: Eastern North American Region (ENAR), International Biometric Society (Member)
2011-Present: International Chinese Statistical Association (ICSA) (Member)
2021: United Kingdom Medical Research Council (Grant reviewer)
2022-Present: Netherlands Organization for Health Research and Development (Grant reviewer)
2024-Present: Dutch Research Council (Grant reviewer)
National
2007-Present: American Statistical Association (ASA) (Member)
2011-2013: American Association for Cancer Research (Member)
2019-Present: American Society for Radiation Oncology (Resident Seed Grant reviewer)
2019, National Institute of Health (NIH), Cancer, Heart, and Sleep Epidemiology Study Sections Panel A (Grant reviewer)
2019-Present: New Approaches to Neuroblastoma Therapy (NANT) Consortium Biology Committee (Standing Member)
2020-Present: Melanoma Research Alliance (Young Investigator Award reviewer)
2021-Present: NRG Oncology Data Monitoring Committee, (Member)
2021: National Institute of Health (NIH), Clinical Oncology Study Section (Grant reviewer)
2021-Present: Data Safety Monitoring Board (DSMB) for “Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer”. PI: Kathryn Schmitz, Penn State College of Medicine (Member)
2021-2022: ASA Biometrics Section, Byar Award Committee (Member)
2022-2023: DSMB for “RAAFT-3 Trial: Radiofrequency Ablation versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation”. PI: Andrea Natale, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, Texas (Member)
2022: NIH, National Institute of Neurological Disorders and Stroke (NINDS), Special Emphasis Panel/Scientific Review Group (Grant reviewer)
2022-Present Conquer Cancer, the American Society of Clinical Oncology (ASCO) Foundation, (Young Investigator Award reviewer)
2022-Present: NIH, Clinical Oncology Study Section (Standing Member)
2023-Present: Department of Defense (DOD), Congressionally Directed Medical Research Programs (CDMRP), (Grant reviewer)
2023-2024: ICSA Annual Symposium Program Committee (Member)
Editorial and Academic Positions
Editorial Positions
2024-Present, Statistical Advisory Panel Member, Nature Medicine
2017-Present, Editorial Board, Journal of National Cancer Institute
2015-2017, Statistical Editor, Journal of National Cancer Institute (JNCI)
Reviewer
2009-Present, Reviewer, Nicotine & Tobacco Research
2013-Present, Reviewer, Statistics in Medicine
2014-Present, Reviewer, Contemporary Clinical Trials
2014-Present, Reviewer, Journal of Clinical Oncology
2015-Present, Reviewer, Clinical Trials
2016-Present, Reviewer, BMC Medical Research Methodology
2017-Present, Reviewer, Communications in Statistics
2019-Present, Reviewer, Biometrika
2019-Present, Reviewer, JNCI Cancer Spectrum
2020-Present, Reviewer, Pediatrics
2020-Present, Reviewer, Cancer
2021-Present, Reviewer, BMC Pediatrics
2021-Present, Reviewer, Blood Advances
2021-Present, Reviewer, Medical Decision Making
2021-Present, Reviewer, JAMA Oncology
2021-Present, Reviewer, Nature Medicine
2022-Present, Reviewer, Nature Communications
2022-Present, Reviewer, Journal of Biopharmaceutical Statistics
2022-Present, Reviewer, SN Comprehensive Clinical Medicine
2023-Present, Reviewer, JACC CardioOncology
Academic and Institutional Committees
2010-Present, Member, Pediatric Protocol Review Committee, Division of Oncology, CHOP
2010-Present, Member, Clinical Research Quality Assurance Committee, Division of Oncology, CHOP
2013Present, Member, Division of Biostatistics Seminar Committee
2013- 2022, Member, Division of Biostatistics Junior Faculty Committee
2014, Member, Division of Biostatistics Strategic Planning Research Programs in Biostatistics
2014-2016, Chair, Division of Biostatistics Seminar Committee
2015-Present, CCEB Appointments Committee
2018-2020, Co-Chair, Division of Biostatistics Junior Faculty Committee
2019-2023, Member, Division of Biostatistics Faculty Recruitment Committee
2021-Present, Co-lead, Clinical Trials Working Group, Center for Cancer Data Science, Penn
2022-Present, Member, Division of Biostatistics Qualify Exam Committee
2023-Present, Member, The Graduate Group in Epidemiology and Biostatistics Award Committee
2024, Member, DBEI Vice Chair for Faculty Professional Development Search Committee
Education & training
Undergraduate Degree
BS in Applied Mathematics - Peking University, Beijing, China
Graduate Degree
PhD in Biostatistics - University of Pennsylvania, Philadelphia, PA
MS in Biostatistics - University of Pennsylvania, Philadelphia, PA
Publications
Publications
2024
Li Y, Nelson R, Izem R, Broglio K, Gamalo M, Mundayat R, Pan H, Sun H, Ye J (2024). Unlocking the potential: A systematic review of master protocol in pediatrics. Therapeutic Innovation & Regulatory Science, 2024 Feb. Online ahead of print
Cao L, Huang YS, Getz K, Seif A, Ruiz J, Miller T, Fisher B, Aplenc R, Li Y: Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data. Pediatric Blood & Cancer 71(3): e30858, Mar 2024
2023
Cao L, Huang YS, Wu C, Getz K, Miller TP, Fisher BT, Fisher B, Seif A, Aplenc R, Li Y: Leveraging machine learning to identify acute myeloid leukemia patients in an administrative database. Pediatric Blood & Cancer 70(5): e30260, May 2023
Blinder J, Huang YS, Rossano JW, Costarino AT, Li Y: Variation in hospital costs and resource utilization after congenital heart surgery. Cardiology in the Young 33(3): 420-431, Mar 2023
2022
Li Y, Sun L, Burstein DS, Getz K: Considerations of competing risks analysis in CardioOncology studies. JACC: CardioOncology 4(3): 287–301, Sept 2022
Li Y, Hwang WT, Maude SL, Teachey DT, Frey NV, Myers RM, Leahy AB, Liu H, Porter DL, Grupp SA, Shaw P: Statistical considerations for time-to-event endpoints in oncology clinical trials: illustrations with CAR-T immunotherapy studies. Clinical Cancer Research 28(18): 3940-3949, Sept 2022
Li Y, Izem R: Novel clinical trial design and analytic methods to tackle challenges in therapeutic development in rare diseases. Annals of Translational Medicine 10(18): 1034, Apr 2022
2021
Bender S, Gamerman V, Reese P, Gray D, Li Y#, Shults J#: The first-order Markov conditional linear expectation approach for analysis of longitudinal data. Statistics in Medicine 40(8): 1972-1988. Apr 2021. # Equal contribution.
2020
Li Y, Yuan Y: PA-CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials. Biometrics 76(4): 1364-1373, Dec 2020
2019
Li Y, Newton J, Getz KD, Huang YS, Seif AE, Fisher BT, Aplenc R, Winestone LE: Comparable on-therapy mortality and supportive care requirements in black and white patients following initial induction for pediatric acute myeloid leukemia. Pediatric Blood & Cancer 66(4): e27583, Apr 2019
Li Y, Wang M, Cheung YK: Treatment and dose prioritization in early phase platform trials of targeted cancer therapies. Journal of the Royal Statistical Society: Series C (Applied Statistics) 68(2): 475-491, Feb 2019.
2018
Mostoufi-Moab S. Sullivan L, LiVolsi V, Li Y, Beaudenon-Huibregtse S, Kazahaya K, Adzick NS, Baloch Z, Labourier E, Bauer AJ: Molecular testing for oncogenic gene alterations in pediatric thyroid lesions. Thyroid 28:60-67, 2018.